Grželj, J.; Marovt, M.; Marko, P.B.; Mlinarič-Raščan, I.; Gmeiner, T.; Šmid, A.
Polymorphism in Gene for ABCC2 Transporter Predicts Methotrexate Drug Survival in Patients with Psoriasis. Medicina 2021, 57, 1050.
https://doi.org/10.3390/medicina57101050
AMA Style
Grželj J, Marovt M, Marko PB, Mlinarič-Raščan I, Gmeiner T, Šmid A.
Polymorphism in Gene for ABCC2 Transporter Predicts Methotrexate Drug Survival in Patients with Psoriasis. Medicina. 2021; 57(10):1050.
https://doi.org/10.3390/medicina57101050
Chicago/Turabian Style
Grželj, Jasna, Maruška Marovt, Pij B. Marko, Irena Mlinarič-Raščan, Tanja Gmeiner, and Alenka Šmid.
2021. "Polymorphism in Gene for ABCC2 Transporter Predicts Methotrexate Drug Survival in Patients with Psoriasis" Medicina 57, no. 10: 1050.
https://doi.org/10.3390/medicina57101050
APA Style
Grželj, J., Marovt, M., Marko, P. B., Mlinarič-Raščan, I., Gmeiner, T., & Šmid, A.
(2021). Polymorphism in Gene for ABCC2 Transporter Predicts Methotrexate Drug Survival in Patients with Psoriasis. Medicina, 57(10), 1050.
https://doi.org/10.3390/medicina57101050